QGP Susceptibilities from PNJL Model

An improved version of the PNJL model is used to calculate various thermodynamical quantities, {\it viz.}, quark number susceptibility, isospin susceptibility, specific heat, speed of sound and conformal measure. Comparison with Lattice data is found to be encouraging.Comment: 4 pages, 2 figures, poster presented at Quark Matter'0

Singularity Free Inhomogeneous Models with Heat Flow

We present a class of singularity free exact cosmological solutions of Einstein's equations describing a perfect fluid with heat flow. It is obtained as generalization of the Senovilla class [1] corresponding to incoherent radiation field. The spacetime is cylindrically symmetric and globally regular.Comment: 6 pages, TeX, to appear in Class.Quant.Gra

Quantum Materials Group Annual Report 2022

The Quantum Materials group at Indian Institute of Technology Patna is working on a range of topics relating to nanoelectronics, spintronics, clean energy and memory design etc. The PI has past experiences of working extensively with superconducting systems like cuprates [1, 2], ruthanate [3], pnictide [4, 5], thin film heterostructures [6, 7] etc and magnetic recording media [8, 9] etc. In this report, we have summarised the ongoing works in our group. We explored a range of functional materials like two-dimensional materials, oxides. topological insulators, organic materials etc. using a combination of experimnetal and computational tools. Some of the useful highlights are as follows: (a) tuning and control of the magnetic and electronic state of 2D magentic materials with rapid enhancement in the Curie temperature, (b) Design and detection of single electron transistor based nanosensors for the detection of biological species with single molecular resolution, (c) Observation of non-volatile memory behaviour in the hybrid structures made of perovskite materials and 2D hybrids. The results offer useful insight in the design of nanoelectronic architecrures for diverse applications

Fusion of 6^{6}Li with 159^{159}Tb} at near barrier energies

Complete and incomplete fusion cross sections for $^{6}$Li+$^{159}$Tb have been measured at energies around the Coulomb barrier by the $\gamma$-ray method. The measurements show that the complete fusion cross sections at above-barrier energies are suppressed by $\sim$34% compared to the coupled channels calculations. A comparison of the complete fusion cross sections at above-barrier energies with the existing data of $^{11,10}$B+$^{159}$Tb and $^{7}$Li+$^{159}$Tb shows that the extent of suppression is correlated with the $\alpha$-separation energies of the projectiles. It has been argued that the Dy isotopes produced in the reaction $^{6}$Li+$^{159}$Tb, at below-barrier energies are primarily due to the $d$-transfer to unbound states of $^{159}$Tb, while both transfer and incomplete fusion processes contribute at above-barrier energies.Comment: Phys. Rev. C (accepted

Falsification of home rapid antigen lateral flow tests during the COVID-19 pandemic

\ua9 The Author(s) 2024. During the COVID-19 pandemic, lateral flow tests (LFTs) were used to regulate access to work, education, social activities, and travel. However, falsification of home LFT results was a concern. Falsification of test results during an ongoing pandemic is a sensitive issue. Consequently, respondents may not answer truthfully to questions about LFT falsification behaviours (FBs) when asked directly. Indirect questioning techniques such as the Extended Crosswise model (ECWM) can provide more reliable prevalence estimates of sensitive behaviors than direct questioning. Here we report the prevalence of LFT FBs in a representative sample in England (n = 1577) using direct questioning (DQ) and the ECWM. We examine the role of demographic and psychological variables as predictors of LFT FBs. We show that the prevalence estimates of the FBs in the DQ condition were significantly lower than the ECWM estimates, e.g., reporting a negative result without conducting a test: 5.7% DQ vs 18.4% ECWM. Moral norms, subjective norms, anticipated regret, perception of risk to self, and trust in government predicted some of the FBs. Indirect questioning techniques can help provide more realistic and higher quality data about compliance with behavioural regulations to government and public health agencies

μ-Bromido-bis{μ-2,2′-[4,7-diaza­decane-1,10-diylbis(nitrilo­methanylyl­idene)]diphenolato}tricopper(II) bromide dimethyl­formamide disolvate

The complex mol­ecule of the title compound, [Cu3Br(C22H28N4O2)2]Br·2C3H7NO, contains three copper atoms, two of which are five-coordinate within a square-pyramidal environment and linked by a bridging Br atom occupying the apical position in each square pyramid. The remaining Cu atom is four-coordinate but with considerable tetra­hedral disortion [the dihedral angle between the two chelate planes is 69.21 (7)°]. There are two mol­ecules of dimethyl­formamide (DMF) present as solvent mol­ecules, one of which is disordered over two equivalent conformations with occupancies of 0.603 (5) and 0.397 (5). The amine H atoms are involved in both inter- and intra­molecular hydrogen-bonding inter­actions with the Br and O atoms of the cation, as well as with the O atom of the ordered DMF mol­ecule

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer

background: SCALOP, a randomised, phase II trial, tested the activity and safety of gemcitabine (GEM)-based and capecitabine (CAP)-based chemoradiation (CRT) for locally advanced pancreatic cancer (LAPC). Here we present the long-term outcomes. methods: Eligibility: histologically proven LAPC less than or equal to7 cm. Following 12 weeks of induction GEMCAP chemotherapy (three cycles: GEM 1000 mg m−2 days 1, 8, 15; CAP 830 mg m−2 days 1–21 q28 days) patients with stable/responding disease, tumour less than or equal to6 cm, and WHO Performance Status 0–1 were randomised to receive one cycle GEMCAP followed by CAP (830 mg m−2 b.d. on weekdays only) or GEM (300 mg m−2 weekly) with radiation (50.4 Gy per 28 fractions). results: One-hundred fourteen patients (28 UK centres) were registered between 24 December 2009 and 25 October 2011, and 74 were randomised (CAP-RT=36; GEM-RT=38). At the time of this analysis, 105 of the 114 patients had died and the surviving 9 patients had been followed up for a median of 10.9 months (IQR: 2.9–18.7). Updated median OS was 17.6 months (95% CI: 14.6–22.7) in the CAP-CRT arm and 14.6 months (95% CI: 11.1–16.0) in the GEM-CRT arm (intention-to-treat adjusted hazard ratio (HR): 0.68 (95% CI: 0.38–1.21, P=0.185)); median progression-free survival (PFS) was 12.0 months (95% CI: 10.0–15.2) in the CAP-CRT arm and 10.4 months (95% CI: 8.8–12.7) in the GEM-CRT arm (intention-to-treat adjusted HR: 0.60 (95% CI: 0.32–1.14, P=0.120)). In baseline multivariable model, age greater than or equal to65 years, better performance status, CA19.9<613 IU l−1, and shorter tumour diameter predicted improved OS. CAP-CRT, age greater than or equal to65 years, better performance status, CA19.9 <46 IU ml−1 predicted improved OS and PFS in the pre-radiotherapy model. Nine-month PFS was highly predictive of OS. conclusions: CAP-CRT remains the superior regimen. SCALOP showed that patients with CA19.9 <46 IU ml−1 after induction chemotherapy are more likely to benefit from CRT